The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894.

Source:http://linkedlifedata.com/resource/pubmed/id/16804926

Cancer 2006 Aug 1 107 3 489-96

Download in:

View as

General Info

PMID
16804926